Cardiac implications for the use of β 2-adrenoceptor agonists for the management of muscle wasting
Systemic administration of β 2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses
The basic secretagogue compound 48/80 activates G proteins indirectly via stimulation of phospholipase D-lysophosphatidic acid receptor axis and 5-HT1A receptors in rat brain sections
Pharmacological characterization of endothelin receptors-mediated contraction in the mouse isolated proximal and distal colon
Regional heterogeneity in the haemodynamic responses to urotensin II infusion in relation to UT receptor localisation
Neuroprotection associated with alternative splicing of NMDA receptors in rat cortical neurons
Long-term bradycardia caused by atrioventricular block can remodel the canine heart to detect the histamine H1 blocker terfenadine-induced torsades de pointes arrhythmias
Comparison of HERG channel blocking effects of various β -blockers - implication for clinical strategy
Gender differences in the slow delayed ( I Ks) but not in inward ( I K1) rectifier K+ currents of canine Purkinje fibre cardiac action potential: key roles for I Ks, β -adrenoceptor stimulation, pacing rate and gender
A small molecule, orally active, α 4 β 1/ α 4 β 7 dual antagonist reduces leukocyte infiltration and airway hyper-responsiveness in an experimental model of allergic asthma in Brown Norway rats
Differential activation of G-proteins by μ -opioid receptor agonists
Substance P-induced cyclooxygenase-2 expression in human umbilical vein endothelial cells
Angiotensin II acutely decreases myocardial stiffness: a novel AT1, PKC and Na+/H+ exchanger-mediated effect